We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Restricted use and new monitoring requirements.
Product defect recall alert for Scabigard Suspension for Cutaneous Administration - Vm 42058/5173 and Vm 60021/3020 by Zoetis Belgium S.A.
The Medicines and Healthcare products Regulatory Agency (MHRA) approved a maximum dose of up to 7.2mg per week of semaglutide (Wegovy) on 6 January 2026.
Reported problems with the supply of an animal medicine and the date when the issue is expected to be resolved.
For manufacturers and distributors of intermediate and final feedingstuffs containing a medicinal premix or specified feed additives in Great Britain and Northern Ireland.
Summary of the latest safety advice for medicines and medical device users
Nearly 20 million doses of potentially dangerous medicines prevented from reaching the public
Details of certificates issued under the Special Import System for the top ten veterinary medicines that were imported 1 July - 30 September 2023.
Applications received to amend the specification of a patent under sections 27 and 75 before the court and the Office.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).